<DOC>
	<DOCNO>NCT02864706</DOCNO>
	<brief_summary>This protocol write describe procedure single 5 , 6 7 year follow-up control visit patient participate 12-month SCHEDULE-study follow 3-year follow-up examination/visit . The aim 5 7-year follow-up visit examine effect long term treatment , i.e . 5 , 6 7 year , early initiation everolimus ( CerticanÂ® ) early elimination cyclosporine ( CsA ) , compare standard immunosuppressive regimen include CsA , renal heart function . During time period follow-up examination , visit perform part routine annual visit 5 , 6 7 year since transplantation ( inclusion original SCHEDULE study ) .</brief_summary>
	<brief_title>SCHEDULE Follow Up Visit 5-7 yr</brief_title>
	<detailed_description />
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Patients participate SCHEDULE 12month main study , complete 3 year followup visit Patients come regular annual clinic visit 5 7 year randomization main study Obtaining separate sign patient inform consent require participation followup examination . Patients retransplanted heart since original SCHEDULE study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>